MedPath

SANDOZ AMPHETAMINE XR

SANDOZ AMPHETAMINE XR

Approved
DIN Number

02457318

Drug Class

Human

Market Date

Dec 22, 2016

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02457318
AIG Number0161310003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA01 AMFETAMINE
Product Specifications
Dosage FormCapsule (Extended Release)
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIXED SALTS AMPHETAMINEActive
Strength: 15 MG
Monograph: MIXED SALTS AMPHETAMINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.